Stocks
Vaxart, Inc.VXRT
OQXHealthcareBiotechnology$0.48
Price as of · delayed, not real-time
A clinical-stage biotechnology company focused on developing oral recombinant vaccines administered by tablet. Its pipeline includes vaccines for infectious diseases such as norovirus, influenza, and COVID-19, attracting investor interest due to its innovative delivery platform and potential for broad applications.
52W Range: $0.31-$0.84
Congressional Interest in Vaxart, Inc. (VXRT)
2 members of Congress have disclosed 2 trades in Vaxart, Inc. (VXRT), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
1
Sells
1
Who in Congress Is Trading VXRT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-12-31 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2015-11-10 | JOHN K. DELANEY | buy | $1K-$15K |